Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000232299

Medchemexpress LLC Pyrimido[4,5-d]pyrimidinone derivative (1-cyclobutyl, 2,6-dimethylphenyl, 2-methoxy-4-piperazinyl) | 2172617-15-9 | 99.8% | 100 MG
SDP

Catalog No. 5000232299
Encompass_Preferred

YKL-06-061 is a potent, selective, second-generation salt-inducible kinase (SIK) inhibitor for research use. It displays low-nanomolar activity against SIK isoforms and is supplied as a purified small-molecule reagent.

  • Potent SIK inhibition (SIK1 = 6.56 nM, SIK2 = 1.77 nM, SIK3 = 20.5 nM).
  • High reported purity (approximately 99.8% by HPLC).
  • Molecular formula C30H37N7O2; molecular weight 527.66 g/mol.
  • Available in multiple sizes and formats, including milligram quantities and a 10 mM solution in DMSO.
  • For research use only; not for human or veterinary applications.

Catalog No. 50-002-32299 Supplier Medchemexpress LLC Supplier No. HY120056100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

YKL-06-061 is a potent, selective, second-generation salt-inducible kinase (SIK) inhibitor for research use. It displays low-nanomolar activity against SIK isoforms and is supplied as a purified small-molecule reagent.

  • Potent SIK inhibition (SIK1 = 6.56 nM, SIK2 = 1.77 nM, SIK3 = 20.5 nM).
  • High reported purity (approximately 99.8% by HPLC).
  • Molecular formula C30H37N7O2; molecular weight 527.66 g/mol.
  • Available in multiple sizes and formats, including milligram quantities and a 10 mM solution in DMSO.
  • For research use only; not for human or veterinary applications.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.